Ad hoc-Service: MorphoSys AG MORPHOSYS(endlich kommen die 1000?)

ots Ad hoc-Service: MorphoSys AG MORPHOSYS SHAREHOLDERS APPROVE CAPITAL INCREASE FOR ACQUISITION PURPOSES


The sender is solely responsible for the contents of this
announcement.
--------------------------------------------------

   Munich, Germany (ots Ad hoc-Service) - MorphoSys AG, the German
biotechnology company, announced today that its shareholders have
authorized a capital increase. The board of management was authorised
by a comfortable majority at yesterday's Annual General Meeting to
increase the company's capital by issuing new shares with a total
nominal value of up to DM 6,350,240. The capital increase was
recommended by the company's management to enable pursuit of an
expanded business strategy which will focus on developing therapeutic
antibodies for the company's own account. The new shares will be used
to acquire capabilities that will enable the company to develop
compounds through phase II clinical trials. The shareholders also
approved all other items on the agenda. In total, approx. 600
shareholders attended the Annual General Meeting, held May 30, 2000
in Planegg / Munich.